Impact of FDG-labelled positron emission tomography imaging on the management of non-small-cell lung cancer
E Salminen, MM Manus - Annals of medicine, 2001 - Taylor & Francis
Lung cancer is currently the leading cause of cancer-related death in both men and women
in most Western countries. Although 5-year survival rates have doubled from 1960s they are …
in most Western countries. Although 5-year survival rates have doubled from 1960s they are …
[HTML][HTML] FDG-PET imaging in the management of non-small-cell lung cancer
E Salminen, M Mac Manus - Annals of oncology, 2002 - Elsevier
Lung cancer is currently the leading cause of cancer-related death in both men and women
in most Western countries. Tumour stage is the strongest prognostic factor and the most …
in most Western countries. Tumour stage is the strongest prognostic factor and the most …
Value of FDG-PET in the management of non-small cell lung cancer
S Stroobants, J Verschakelen… - European journal of …, 2003 - Elsevier
In the past 5 years, metabolic imaging with positron emission tomography (PET) using 18F-
fluoro-2-deoxy-glucose (FDG) has become an important imaging modality in lung cancer …
fluoro-2-deoxy-glucose (FDG) has become an important imaging modality in lung cancer …
Value of FDG PET in the management of NSCLC
D Ukena, D Hellwig - Lung cancer, 2004 - Elsevier
Metabolic imaging with positron emission tomography (PET) using 18F-fluoro-2-deoxy-
glucose (FDG) has been accepted as an important imaging modality in lung cancer. FDG …
glucose (FDG) has been accepted as an important imaging modality in lung cancer. FDG …
FDG-PET/CT in lung cancer: an update
The prognosis of lung cancer patients mostly depends on the stage at which the disease is
diagnosed. Contrast-enhanced CT (ceCT) and MRI play a significant role in initial staging …
diagnosed. Contrast-enhanced CT (ceCT) and MRI play a significant role in initial staging …
Lung cancer and positron emission tomography with fluorodeoxyglucose
EM Marom, JJ Erasmus, EF Patz Jr - Lung Cancer, 2000 - Elsevier
Over the past years, positron emission tomography (PET) with fluoro-2-deoxy-d-glucose
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …
Prognosis and reevaluation of lung cancer by positron emission tomography imaging
JJ Erasmus, E Rohren, SG Swisher - Proceedings of the American …, 2009 - atsjournals.org
Positron emission tomography (PET) imaging using 18F-2-deoxy-D-glucose, a D-glucose
analog labeled with fluorine-18 (FDG-PET), is being evaluated in the assessment of …
analog labeled with fluorine-18 (FDG-PET), is being evaluated in the assessment of …
PET-CT in the staging and treatment of non-small-cell lung cancer
P Ibeas, B Cantos, JM Gasent, B Rodríguez… - Clinical and …, 2011 - Springer
Abstract Positron emission tomography with 2-(18 F)-fluoro-2-deoxy-D-glucose (FDG-PET)
is a metabolic imaging technique. FDG-PET is more accurate than CT for the evaluation of …
is a metabolic imaging technique. FDG-PET is more accurate than CT for the evaluation of …
Role of FDG-PET in the diagnosis and management of lung cancer
WJG Oyen, J Bussink, AFT Verhagen… - Expert review of …, 2004 - Taylor & Francis
Positron emission tomography (PET) using [18F]-2-deoxy-2-fluoro-d-glucose (FDG) has
emerged as a valuable diagnostic modality in patients with non-small cell lung cancer …
emerged as a valuable diagnostic modality in patients with non-small cell lung cancer …
[HTML][HTML] Positron emission tomography/computerized tomography in lung cancer
I Sahiner, GU Vural - Quantitative Imaging in Medicine and Surgery, 2014 - ncbi.nlm.nih.gov
Positron emission tomography (PET) using 2-(18F)-flouro-2-deoxy-D-glucose (FDG) has
emerged as a useful tool in the clinical work-up of lung cancer. This review article provides …
emerged as a useful tool in the clinical work-up of lung cancer. This review article provides …